[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes

NCT07238322 · clinicaltrials.gov ↗

COMPLETED

Status

253

Enrollment

INDUSTRY

Sponsor class

Conditions

Retrospective Study
Glioma
Brain Neoplasms

Interventions

DIAGNOSTIC_TEST: 18F(FET)PET

Sponsor

Telix Pharmaceuticals (Innovations) Pty Limited